ロード中...
lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141
BACKGROUND: 5-Fluorouracil (5-FU) has been widely applied to treat various types of cancers, including hepatocellular carcinoma (HCC). However, primary or acquired 5-FU resistance prevents the clinical application of this drug in cancer therapy. Herein, our study is the first to demonstrate that low...
保存先:
| 出版年: | Cell Commun Signal |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6098660/ https://ncbi.nlm.nih.gov/pubmed/30119680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-018-0260-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|